SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Encysive Pharmaceuticals (ENCY)
An SI Board Since November 2005
Posts SubjectMarks Bans
205 11 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
180Encysive Down on 4th-Quarter Loss, PeopleSupport Plunges; Jones Rises on 4Q Profidos-3/9/2007
179>>THELIN (sitaxentan sodium) Receives Australian Marketing Approval Wednestuck-3/7/2007
178ency pdufa is 6/15. Gild 6/18. gild is 2 days early, ency is 1 day late, they herkrw-2/16/2007
177>>Gilead's New Drug Application for Ambrisentan Receives Priority Revituck-2/16/2007
176Confusing logic to link the ency move to gsk/praecis. 12% interest rate is sterkrw-2/7/2007
175Encysive shares buoyed by GlaxoSmithKline news bizjournals.com Wednesday FebruaDoc Bones-2/7/2007
174For curiosity I looked up some archives of sitaxsentan. 6/00: Partnership withrkrw-1/6/2007
173Think I may finally understand the mysterious regulatory hurdle Thelin's trytuck-1/6/2007
172 ENCY Encysive Pharma: No insight into the regulatory issue at hand- OppenheimerIRWIN JAMES FRANKEL-12/29/2006
171I wonder if (like everyone else) they concluded the class I review last time mearkrw-12/29/2006
170 ENCY Encysive Pharma: FDA assigns 6 month review to Thelin, adds uncertainty toIRWIN JAMES FRANKEL-12/29/2006
169CC gave no color on the FDA class 2. Perhaps this situation was caused by FDA dIRWIN JAMES FRANKEL-12/28/2006
168The put sale looks good. This has the "feel" of the FDA slapping themIRWIN JAMES FRANKEL-12/28/2006
167We and Street were hoping for class 1. ENCY down 11% as I type. I think it firtuck-12/28/2006
166FDA Accepts Encysive's Complete Response to THELIN New Drug Application ThurIRWIN JAMES FRANKEL-12/28/2006
165>>Gilead Submits New Drug Application To U.S. FDA for Ambrisentan for the tuck-12/19/2006
164>>Encysive Pharmaceuticals Announces Launch of Thelin in Germany Monday Detuck-12/18/2006
163Good one!rkrw-12/16/2006
162Perhaps all ENCY's share holders will be able to celebrate thanks Given on Fidos-12/16/2006
161A name like that is bound to be misspelled. Given, Givens, Givin, Givins. JNJ barkrw-12/15/2006
160Here's the background of the team, FWIW, with Given headlining: encysive.cotuck-12/15/2006
159>>Encysive Pharmaceuticals' THELIN (sitaxentan sodium) Receives Positituck-12/15/2006
158Hope your order got filled, it will probably bounce today. Best, idoidos-12/15/2006
157The word "productive" was selected to avoid saying something more poinIRWIN JAMES FRANKEL-12/15/2006
156Givens when he first came in was very highly thought of for whatever reason. I drkrw-12/15/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News